Jan Willem Alffenaar

Zoekresultaten

• 2022

  Corrigendum to "Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs" [Clin. Mass Spectrom. 14(Part A) (2019) 34-45]

  Kuhlin, J., Sturkenboom, M. G. G., Ghimire, S., Margineanu, I., van den Elsen, S. H. J., Simbar, N., Akkerman, O. W., Jongedijk, E. M., Koster, R. A., Bruchfeld, J., Touw, D. J. & Alffenaar, J.-W. C., aug.-2022, In: Journal of mass spectrometry and advances in the clinical lab. 25, blz. 72

  Onderzoeksoutput

  Open Access

  Bestand

  • Therapeutic Drug Monitoring 100%
  • Salicylate Sodium 100%
  • 2,5-Dimethoxy-4-iodoamphetamine 100%
  • Tuberculostatic Agent 100%
  • Mass Spectrometry 100%
  1 Citaat (Scopus)

  43 Downloads (Pure)